Technology area: Biotechnology & Pharmaceuticals
16 pending office actions • 12 clients • 14 examiners • 12 art units • 0 of 16 (0%) have an AI response strategy ready
Nevrivy Patent Law Group P.L.L.C. records 16 pending office actions in Biotechnology & Pharmaceuticals and 461 career applications. The profile shows an active life-sciences workload alongside a more limited historical application record.
The resolved allowance rate is 84.48%, with an average of 4.55 office actions per allowance. Resolved matters reached allowance in a substantial portion of the record, but allowed matters generally involved extended examination activity.
Practitioners should examine how biological and pharmaceutical claims were supported through repeated responses, particularly where written description, enablement, or prior-art distinctions shaped prosecution. The pending-action total also warrants active prioritization of current response obligations.
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (6%) |
| §102 only | 1 (6%) |
| §112 only | 4 (25%) |
| Double-patenting + other | 1 (6%) |
| Multi-statute (no §101) | 9 (56%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BREEN, KIMBERLY CATHERINE | 2 | 23.8% | +56.3% |
| MINCHELLA, KAITLYN L | 2 | 26.4% | +21.7% |
| FERNANDEZ, SUSAN EMILY | 1 | 52.3% | +60.9% |
| GRABER, JAMES J | 1 | 46.5% | +57.6% |
| RAGHU, GANAPATHIRAM | 1 | 73.7% | +26.5% |
| KIM, JAY C | 1 | 49.4% | +21.6% |
| MORELLO, JEAN F | 1 | 68.8% | +8.7% |
| SCHLOOP, ALLISON ELIZABETH | 1 | 63.3% | +47.6% |
| DEVI, SARVAMANGALA | 1 | 65.5% | +55.5% |
| XIAO, YAN | 1 | 67.3% | +52.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17255570 | METHODS OF TREATING OR PREVENTING MUCORMYCOSIS | CHEONG, CHEOM-GIL | 25d overdue |
| 15028253 | METHODS FOR DISTINGUISHING INFLAMMATORY BOWEL DISEASES USING MICROBIAL COMMUNITY SIGNATURES | MINCHELLA, KAITLYN L | 14d |
| 15489658 | METHODS FOR DISTINGUISHING INFLAMMATORY BOWEL DISEASES USING MICROBIAL COMMUNITY SIGNATURES | MINCHELLA, KAITLYN L | 21d |
| 18988370 | FREEZE-DRIED PROBIOTIC FOODSTUFFS | FERNANDEZ, SUSAN EMILY | — |
| 18854936 | ENZYME-FREE PROCESSES TO PRODUCE HYDROGELS | GRABER, JAMES J | — |
| 18852356 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF STROKE | RAGHU, GANAPATHIRAM | — |
| 18827601 | DETECTION OF CREATINE LEVELS USING ENZYME COMPOSITIONS | BREEN, KIMBERLY CATHERINE | — |
| 18691382 | INTERNAL DUCT INTEGRITY INSPECTION EQUIPMENT USING MAGNETIC METAL MEMORY | MORELLO, JEAN F | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18332359 | A MULTIPLEX CRISPR BASED ASSAY FOR THE SIMULTANEOUS DETECTION OF CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE | SCHLOOP, ALLISON ELIZABETH | 18d overdue |
| 17909423 | LIVE SALMONELLA TYPHI VECTORS ENGINEERED TO EXPRESS PROTEIN ANTIGENS AND METHODS OF USE THEREOF | DEVI, SARVAMANGALA | 18d overdue |
| 15028253 | METHODS FOR DISTINGUISHING INFLAMMATORY BOWEL DISEASES USING MICROBIAL COMMUNITY SIGNATURES | MINCHELLA, KAITLYN L | 14d |
| 15489658 | METHODS FOR DISTINGUISHING INFLAMMATORY BOWEL DISEASES USING MICROBIAL COMMUNITY SIGNATURES | MINCHELLA, KAITLYN L | 21d |
| 18988370 | FREEZE-DRIED PROBIOTIC FOODSTUFFS | FERNANDEZ, SUSAN EMILY | — |
| 18854936 | ENZYME-FREE PROCESSES TO PRODUCE HYDROGELS | GRABER, JAMES J | — |
| 18852356 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF STROKE | RAGHU, GANAPATHIRAM | — |
| 18827601 | DETECTION OF CREATINE LEVELS USING ENZYME COMPOSITIONS | BREEN, KIMBERLY CATHERINE | — |
| Art Unit | Apps |
|---|---|
| 1645 | 3 |
| 1657 | 2 |
| 1685 | 2 |
| 1651 | 1 |
| 1631 | 1 |
| 1652 | 1 |
| 2815 | 1 |
| 2855 | 1 |
| 1683 | 1 |
| 1642 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18988370 | FREEZE-DRIED PROBIOTIC FOODSTUFFS | Imagilin Technology, LLC | FERNANDEZ, SUSAN EMILY | 1651 | §102§103§112 | Non-Final OA | — | Pending | Dec 19, 2024 |
| 18854936 | ENZYME-FREE PROCESSES TO PRODUCE HYDROGELS | Tissuelabs Pesquisa E Desenvolvimento Ltda | GRABER, JAMES J | 1631 | §102§103§112 | Non-Final OA | — | Pending | Oct 07, 2024 |
| 18852356 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF STROKE | The United States Department of Veterans Affairs | RAGHU, GANAPATHIRAM | 1652 | §102§103§112 | Non-Final OA | — | Pending | Sep 27, 2024 |
| 18827601 | DETECTION OF CREATINE LEVELS USING ENZYME COMPOSITIONS | Ip2Ipo Innovations Limited | BREEN, KIMBERLY CATHERINE | 1657 | §103§112 | Non-Final OA | — | Pending | Sep 06, 2024 |
| 18818538 | TUNED MATERIALS, TUNED PROPERTIES, AND TUNABLE DEVICES FROM ORDERED OXYGEN VACANCY COMPLEX OXIDES | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | KIM, JAY C | 2815 | §112 | Non-Final OA | — | Pending | Aug 28, 2024 |
| 18691382 | INTERNAL DUCT INTEGRITY INSPECTION EQUIPMENT USING MAGNETIC METAL MEMORY | Pipeway Engenharia Ltda | MORELLO, JEAN F | 2855 | §102§103§112 | Non-Final OA | — | Pending | Mar 12, 2024 |
| 18332359 | A MULTIPLEX CRISPR BASED ASSAY FOR THE SIMULTANEOUS DETECTION OF CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE | The Penn State Research Foundation | SCHLOOP, ALLISON ELIZABETH | 1683 | §112 | Final Rejection | 18d overdue | Pending | Jun 09, 2023 |
| 17909423 | LIVE SALMONELLA TYPHI VECTORS ENGINEERED TO EXPRESS PROTEIN ANTIGENS AND METHODS OF USE THEREOF | National Research Council Of Canada | DEVI, SARVAMANGALA | 1645 | §112 | Final Rejection | 18d overdue | Pending | Sep 05, 2022 |
| 17778536 | BROADLY NEUTRALIZING AND POTENT ANTIBODIES AGAINST HIV | The United States Department of Health and Human Services | XIAO, YAN | 1642 | §102§112Other | Non-Final OA | — | Pending | May 20, 2022 |
| 17625059 | TREATMENT OF PULMONARY FIBROSIS USING INHIBITORS OF NEU1 SIALIDASE | The United States Department of Veterans Affairs | COLEMAN, BRENDA LIBBY | 1624 | §102 | Non-Final OA | — | Pending | Jan 05, 2022 |
| 17616584 | ADJUVANTS FOR IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF | UNIVERSITY OF MARYLAND, BALTIMORE | HIBSHMAN, SARAH GRACE | 1693 | §103 | Final Rejection | 34d | Pending | Dec 03, 2021 |
| 17172860 | COMPOSITIONS COMPRISING PROBIOTICS AND METHODS OF USE THEREOF | Imagilin Technology LLC | BREEN, KIMBERLY CATHERINE | 1657 | §103DP | Final Rejection | — | Pending | Feb 10, 2021 |
| 17255570 | METHODS OF TREATING OR PREVENTING MUCORMYCOSIS | Los Angeles Biomedical Research Institute AT Harbor AT Ucla Medical Center | CHEONG, CHEOM-GIL | 1645 | §103§112 | Final Rejection | 25d overdue | Pending | Dec 23, 2020 |
| 16331863 | THERMOSTABLE VARIANTS OF P. FALCIPARUM PFRH5 WHICH CAN BE PRODUCED IN BACTERIAL CELLS | Yeda Research And Development Co. Ltd. | ZEMAN, ROBERT A | 1645 | §112 | Non-Final OA | — | Pending | Mar 08, 2019 |
| 15489658 | METHODS FOR DISTINGUISHING INFLAMMATORY BOWEL DISEASES USING MICROBIAL COMMUNITY SIGNATURES | UNIVERSITY OF MARYLAND, BALTIMORE | MINCHELLA, KAITLYN L | 1685 | §103§112 | Final Rejection | 21d | Pending | Apr 17, 2017 |
| 15028253 | METHODS FOR DISTINGUISHING INFLAMMATORY BOWEL DISEASES USING MICROBIAL COMMUNITY SIGNATURES | UNIVERSITY OF MARYLAND, BALTIMORE | MINCHELLA, KAITLYN L | 1685 | §102§112Other | Final Rejection | 14d | Pending | Apr 08, 2016 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial84.5% of resolved applications prosecuted by Nevrivy Patent Law Group P.L.L.C. were allowed, across 461 applications in USPTO records.
4.55 office actions per allowed application on average.
16 pending office actions as of October 2026, for 12 clients, before 14 examiners in 12 art units.
